These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37643074)

  • 1.
    A S S; Thapliyal A; Pant K
    J Biomol Struct Dyn; 2024 Nov; 42(18):9678-9690. PubMed ID: 37643074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway.
    Chen F; Chen Y; Ke Q; Wang Y; Gong Z; Chen X; Cai Y; Li S; Sun Y; Peng X; Ji Y; Zhang T; Wu W; Cui L; Wang Y
    J Transl Med; 2023 Feb; 21(1):103. PubMed ID: 36759834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients.
    Zhang H; Shao L; Lin Z; Long QX; Yuan H; Cai L; Jiang G; Guo X; Yang R; Zhang Z; Zhang B; Liu F; Li Z; Ma Q; Zhang YW; Huang AL; Wang Z; Zhao Y; Xu H
    Signal Transduct Target Ther; 2022 Aug; 7(1):261. PubMed ID: 35915083
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive examination of ACE2 receptor and prediction of spike glycoprotein and ACE2 interaction based on
    Aktaş E; Özdemir Özgentürk N
    J Biomol Struct Dyn; 2024 Jun; 42(9):4412-4428. PubMed ID: 37349943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.
    Paiardi G; Ferraz M; Rusnati M; Wade RC
    Proc Natl Acad Sci U S A; 2024 Oct; 121(43):e2404892121. PubMed ID: 39401361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spike Protein of SARS-CoV-2 Activates Cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-κB Signaling.
    Van Tin H; Rethi L; Higa S; Kao YH; Chen YJ
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain.
    Banerjee T; Gosai A; Yousefi N; Garibay OO; Seal S; Balasubramanian G
    J Biomol Struct Dyn; 2024 Aug; 42(12):6342-6358. PubMed ID: 37424217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
    Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P
    Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational perturbation of SARS-CoV-2 spike protein using N-acetyl cysteine: an exploration of probable mechanism of action to combat COVID-19.
    Debnath U; Mitra A; Dewaker V; Prabhakar YS; Tadala R; Krishnan K; Wagh P; Velusamy U; Baliyan A; Kurpad AV; Bhattacharyya P; Mandal AK
    J Biomol Struct Dyn; 2024 Jul; 42(10):5042-5052. PubMed ID: 37477247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.
    Ortuso F; Mercatelli D; Guzzi PH; Giorgi FM
    J Biomol Struct Dyn; 2022 Sep; 40(14):6545-6555. PubMed ID: 33583326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.